Atossa Therapeutics
ATOS
$1.66
Share price
9.21%
Change (1 day)
159.38%
Change (1 year)
Categories
Operating Margin for Atossa Therapeutics (ATOS)
Operating Margin as of May 2024 (TTM): -725,722.00%
According to Atossa Therapeutics's latest financial reports and stock price the company's current Operating Margin is -725,722.00%. At the end of 2015 the company had an Operating Margin of -725,721.67%.
Operating Margin history for Atossa Therapeutics from 2012 to 2015
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2015 | -725,721.67% | 25940.26% |
| 2014 | -2,786.92% | 63.46% |
| 2013 | -1,704.94% | 61.72% |
| 2012 | -1,054.26% | -99.54% |
| 2011 | -229,484.60% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.00% | 🇺🇸 USA |
 Quest Diagnostics
DGX | 11.10% | -100.00% | 🇺🇸 USA |
 LabCorp LH | 10.63% | -100.00% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | 18.52% | -100.00% | 🇺🇸 USA |
 NeoGenomics
NEO | -31.26% | -100.00% | 🇺🇸 USA |
 Enzo Biochem ENZ | -43.44% | -99.99% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.